Nestruck A C, Rubinstein D
Can J Biochem. 1976 Jul;54(7):617-28. doi: 10.1139/o76-091.
The incorporation of [3H]leucine in vivo into very low density lipoproteins (VLDL) from the rat hepatic Golgi apparatus and serum was studied. A Golgi-rich fraction isolated on a discontinuous sucrose gradient between 0.5 and 1.1 M was found to contain VLDL having common antigenic determinants with serum VLDL. The incorporation of the [3H]leucine into the Golgi VLDL and serum VLDL suggested a precursor-product relationship. Analysis of the apoproteins of the Golgi VLDL by polacrylamide gel electrophoresis revealed protein bands with similar mobility to those of serum VLDL, except that the former contained virtually no rapidly migrating peptides with the mobility of serum apo-C-II and apo-C-III. The pattern of incorporation of the [3H]leucine into the apoproteins was similar in VLDL from Golgi apparatus and serum, except for the absence of radioactivity in the area of the gel of Golgi apo-VLDL corresponding to apo-C-II and apo-C-III. The radioactive amino acid was incorporated predominantly into the Golgi apo-VLDL bands with similar mobility to apo-B and an apoprotein or group of apoproteins containing the arginine-rich peptide of serum VLDL. In vitro incubation of the Golgi VLDL with [3H]leucine-labeled HDL resulted in the acquisition of a number of proteins, including the rapidly migrating proteins. Administration of colchicine prior to the injection of [3H]leucine resulted in the appearance of gel bands and radioactivity in the apo-C-II and apo-C-III areas of Golgi apo-VLDL, suggesting that these can be acquired if secretion of VLDL is slowed or inhibited. The hepatic Golgi apparatus was then divided into fractions of predominantly forming face (GF3) or secretory granules (GF1). After polyacrylamide gel electrophoresis of the apo-VLDL from GF, no visible bands or incorporation of [3H]leucine was found in the region of apo-C-II or apo-C-III. However VLDL from GF1, showed visible and radioactive bands in the apo-C-II and apo-C-III area although they represented a much smaller proportion of the total apoprotein than was found in the corresponding serum apo-VLDL. In the isolated perfused liver the percentage incorporation of [3H]leucine into the rapidly migrating apoproteins of Golgi VLDL was considerably less than that found in the corresponding apoproteins of perfusate VLDL, where circulating C lipoproteins are virtually absent. The data indicate that nascent VLDL begins to acquire the C-II and C-III apoproteins during its passage through the Golgi apparatus but that the main acquisition occurs during or after secretion into the space of Disse.
研究了[3H]亮氨酸在体内掺入大鼠肝脏高尔基体和血清中极低密度脂蛋白(VLDL)的情况。在0.5至1.1M的不连续蔗糖梯度上分离得到的富含高尔基体的部分,发现含有与血清VLDL具有共同抗原决定簇的VLDL。[3H]亮氨酸掺入高尔基体VLDL和血清VLDL表明存在前体-产物关系。通过聚丙烯酰胺凝胶电泳分析高尔基体VLDL的载脂蛋白,发现其蛋白带迁移率与血清VLDL相似,只是前者几乎不含有迁移速度快的肽,其迁移率与血清载脂蛋白C-II和载脂蛋白C-III相同。[3H]亮氨酸掺入载脂蛋白的模式在高尔基体和血清的VLDL中相似,只是在高尔基体载脂蛋白-VLDL凝胶中对应于载脂蛋白C-II和载脂蛋白C-III的区域没有放射性。放射性氨基酸主要掺入迁移率与载脂蛋白B相似的高尔基体载脂蛋白-VLDL带以及含有血清VLDL富含精氨酸肽的一种或一组载脂蛋白中。高尔基体VLDL与[3H]亮氨酸标记的高密度脂蛋白(HDL)进行体外孵育,导致获得了一些蛋白质,包括迁移速度快的蛋白质。在注射[3H]亮氨酸之前给予秋水仙碱,导致高尔基体载脂蛋白-VLDL的载脂蛋白C-II和载脂蛋白C-III区域出现凝胶带和放射性,表明如果VLDL的分泌减慢或受到抑制,这些载脂蛋白可以获得。然后将肝脏高尔基体分为主要是形成面的部分(GF3)或分泌颗粒(GF1)。对来自GF的载脂蛋白-VLDL进行聚丙烯酰胺凝胶电泳后,在载脂蛋白C-II或载脂蛋白C-III区域未发现可见带或[3H]亮氨酸的掺入。然而,来自GF1的VLDL在载脂蛋白C-II和载脂蛋白C-III区域显示出可见的放射性带,尽管它们在总载脂蛋白中所占比例远小于相应血清载脂蛋白-VLDL中的比例。在离体灌注肝脏中,[3H]亮氨酸掺入高尔基体VLDL快速迁移载脂蛋白的百分比远低于灌注液VLDL相应载脂蛋白中的百分比,而灌注液中几乎不存在循环中的C脂蛋白。数据表明,新生VLDL在通过高尔基体的过程中开始获得载脂蛋白C-II和载脂蛋白C-III,但主要的获得过程发生在分泌到狄氏间隙期间或之后。